Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novartis presents novel anti-BAFF-R afucosylated human antibody

Dec. 11, 2013

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Sunovion presents the discovery of novel selective mGlu5 PAMs

Dec. 11, 2013

Novel CB2 agonists demonstrate efficacy in animal models of inflammatory pain

Dec. 11, 2013

ImQuest BioSciences presents a novel anti-HIV microbicide gel

Dec. 11, 2013

Development of novel 5-HT2C PAMs for neurological disorders

Dec. 10, 2013

First-in-human phase I study reported for SGN-CD19A

Dec. 10, 2013

Characterization of novel cocaine metabolizing enzymes for treatment of addiction

Dec. 10, 2013

Phase Ib data for MP-4-CO in patients with sickle cell anemia

Dec. 9, 2013

MUC-1 cancer vaccine well tolerated in phase I study

Dec. 9, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...